What Researchers Did
Researchers analyzed data from a registry of 2538 patients with various radiation injuries to evaluate the outcomes and treatment parameters of hyperbaric oxygen therapy.
What They Found
The study analyzed 2538 patients across 10 types of radiation injuries, with osteoradionecrosis (33.4%) and dermal soft tissue radionecrosis (27.5%) being the most common. Following hyperbaric oxygen therapy, symptoms improved or resolved in 76.7% to 92.6% of patients, depending on the specific injury type.
What This Means for Canadian Patients
For Canadian patients experiencing late effects of radiation therapy, this study suggests that hyperbaric oxygen therapy (HBOT) can be an effective adjunctive treatment. Patients suffering from conditions like osteoradionecrosis or radiation cystitis may see significant improvement or resolution of their symptoms with HBOT.
Canadian Relevance
This study covers delayed radiation injuries, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As an observational cohort study, it cannot establish cause and effect, and some statistically significant differences in symptom improvement may not be clinically meaningful.